Zealand Pharma A/S reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was DKK 13.63 million compared to DKK 10.96 million a year ago. Net loss was DKK 193.63 million compared to DKK 222.85 million a year ago.

Basic loss per share from continuing operations was DKK 3.76 compared to DKK 2.2 a year ago. Basic loss per share was DKK 3.76 compared to DKK 5.16 a year ago.